scPharmaceuticals Inc. (SCPH)
NASDAQ: SCPH · Real-Time Price · USD
5.58
+0.01 (0.18%)
Sep 8, 2025, 4:00 PM - Market closed
scPharmaceuticals Employees
As of December 31, 2024, scPharmaceuticals had 164 total employees, including 162 full-time and 2 part-time employees. The number of employees increased by 28 or 20.59% compared to the previous year.
Employees
164
Change (1Y)
28
Growth (1Y)
20.59%
Revenue / Employee
$304,689
Profits / Employee
-$559,244
Market Cap
299.53M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 164 | 28 | 20.59% |
| Dec 31, 2023 | 136 | 40 | 41.67% |
| Dec 31, 2022 | 96 | 70 | 269.23% |
| Dec 31, 2021 | 26 | -1 | -3.70% |
| Dec 31, 2020 | 27 | 10 | 58.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SCPH News
- 13 days ago - SCPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of scPharmaceuticals Inc. - SCPH - Business Wire
- 14 days ago - MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases - GlobeNewsWire
- 25 days ago - scPharmaceuticals Receives Notice of Allowances of Multiple US Patent Applications Covering SCP-111 - GlobeNewsWire
- 4 weeks ago - scPharmaceuticals Inc. (SCPH) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - scPharmaceuticals Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 5 weeks ago - scPharmaceuticals to Announce Second Quarter 2025 Financial Results After the Market Close on August 7, 2025 - GlobeNewsWire
- 3 months ago - scPharmaceuticals: Furoscix Sales To Accelerate Throughout 2025 - Seeking Alpha
- 4 months ago - scPharmaceuticals Inc. (SCPH) Q1 2025 Earnings Call Transcript - Seeking Alpha